CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CANbridge Pharmaceuticals Inc. announces the composition of its Board of Directors, including the Chairman and CEO, Dr. James Qun Xue, along with a list of Non-executive and Independent Non-executive Directors. The company also outlines the structure of its three Board committees, specifying the chairpersons and members of each.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.